The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
Open accessAbstract
The administration of nanoparticles (NPs) first faces the challenges of evading renal filtration and clearance of reticuloendothelial system (RES). After that, NPs infiltrate through the expanded endothelial space and penetrated the dense stroma of tumor microenvironment to tumor cells. As long as possible to prolong the time of NPs remaining in tumor tissue, NPs release active agent and induce pharmacological action. This review provides a comprehensive summary of the physical and chemical properties of NPs and the influence of various biological factors in tumor microenvironment, and discusses how to improve the final efficacy through adjusting the characteristics and structure of NPs. Perspectives and future directions are also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–251 of 251
MnO2-Based Nanoplatform Serves as Drug Vehicle and MRI Contrast Agent for Cancer Theranostics
Zhang, M., Xing, L., Ke, H., He, Y., Cui, P., Zhu, Y., Jiang, G., Qiao, J.-B., Lu, N., Chen, H., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b15247 · Cited by 100
Self-citationWu, X., Chen, X., Zhou, Q., Li, P., Yu, B., Li, J., Qu, Y., Yan, J., Yu, Y., Yan, M., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.002 · Cited by 98
Effect of gold nanoparticle shapes for phototherapy and drug delivery
Adnan, N. N. M., Cheng, Y., Ong, N. M. N., Kamaruddin, T. T., Rozlan, E., Schmidt, T. W., Duong, H. T. T., & Boyer, C. A. (2016) · Polymer Chemistry · doi:10.1039/c6py00465b · Cited by 98
Li, X., Wu, M., Pan, L., & Shi, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s81156 · Cited by 94
iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas
Kang, T., Gao, X., Hu, Q., Jiang, D., Feng, X., Zhang, X., Song, Q., Yao, L., Huang, M., Jiang, X., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.082 · Cited by 93
Pei, Y., Liang, C., Huang, Y., Wang, J., Feng, J., Xu, M., Chen, Y., Song, Q., Jiang, G., Gu, X. Q., et al. (2019) · Small · doi:10.1002/smll.201900631 · Cited by 93
Huang, N., Liu, Y., Fang, Y. V., Zheng, S., Wu, J., Wang, M., Zhong, W., Shi, M., Xing, M. M. Q., & Liao, W. (2020) · ACS Nano · doi:10.1021/acsnano.9b08460 · Cited by 93
Self-citationHou, L., Liu, Q., Shen, L., Liu, Y., Zhang, X., Chen, F., & Huang, L. (2018) · Theranostics · doi:10.7150/thno.24821 · Cited by 91
Self-citationHypoxia-tropic Protein Nanocages for Modulation of Tumor- and Chemotherapy-Associated Hypoxia
Huang, X., Zhuang, J., Chung, S. W., Huang, B., Halpert, G., Negrón, K., Sun, X., Yang, J., Oh, Y., Hwang, P. M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b05399 · Cited by 84
Viña‐Vilaseca, A., Bender–Sigel, J., Sorkina, T., Closs, E. I., & Sorkin, A. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186858 · Cited by 79
Torosean, S., Flynn, B. P., Axelsson, J., Gunn, J. R., Samkoe, K. S., Hasan, T. G., Doyley, M. M., & Pogue, B. W. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.07.002 · Cited by 79
Zhang, Q., Deng, C., Fu, Y. S., Sun, X., Gong, T., & Zhang, Z. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00952 · Cited by 79
Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer
Sims, L. B., Curtis, L. T., Frieboes, H. B., & Steinbach-Rankins, J. M. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0185-x · Cited by 73
PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma
Gaudin, A., Song, E., King, A. R., Saucier-Sawyer, J. K., Bindra, R. S., Desmaële, D., Couvreur, P., & Saltzman, W. M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.037 · Cited by 68
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylation
Hennig, R., Pollinger, K., Veser, A., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.062 · Cited by 67
Fang, T., Zhang, J., Zuo, T., Wu, G., Xu, Y., Yang, Y., Yang, J., & Shen, Q. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c10416 · Cited by 67
Fan, B., & Gillies, E. R. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00030 · Cited by 66
VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells
Shein, S. A., Kuznetsov, I. I., Abakumova, T. O., Chelushkin, P. S., Melnikov, P., Korchagina, A. A., Bychkov, D. A., Seregina, I. F., Bolshov, M. A., Kabanov, A. V., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00519 · Cited by 65
Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery
Kim, S. J., Jung, K. H., Son, M. K., Park, J. H., YAN, H. H., Fang, Z., Kang, Y. W., Han, B., Lim, J. H., & Hong, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.035 · Cited by 60
Renal Clearable Bi–Bi 2 S 3 Heterostructure Nanoparticles for Targeting Cancer Theranostics
Dong, L., Zhang, P., Liu, X., Deng, R., Du, K., Feng, J., & Zhang, H. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b21280 · Cited by 60
Self-citationJiang, Y., Pang, X., Liu, R., Xiao, Q., Wang, P., Leung, A. W., Luan, Y., & Xu, C. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11699 · Cited by 54
Brekken, C., & Davies, C. D. L. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00202-x · Cited by 53
Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery
Betker, J. L., Jones, D., Childs, C. R., Helm, K. M., Terrell, K. L., Nagel, M. A., & Anchordoquy, T. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.031 · Cited by 53
Zhang, D., Chu, Y., Qian, H., Qian, L., Shao, J., Xu, Q., Yu, L., Li, R., Zhang, Q., Wu, F., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s231448 · Cited by 53
Chen, Y., Su, M., Li, Y., Gao, J., Zhang, C., Cao, Z., Zhou, J., Liu, J., & Jiang, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10148 · Cited by 51
Ahmad, A., Mondal, S. K., Mukhopadhyay, D., Banerjee, R., & Alkharfy, K. M. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00900 · Cited by 49
Yu, C., He, B., Xiong, M., Zhang, H., Yuan, L., Ma, L., Dai, W., Wang, J., Wang, X., Wang, X., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.006 · Cited by 48
Singh, Y., Srinivas, A., Gangwar, M., Meher, J. G., Misra‐Bhattacharya, S., & Chourasia, M. K. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00206 · Cited by 48
Yamamoto, S., Kato, A., Sakurai, Y., Hada, T., & Harashima, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.010 · Cited by 48
Rapoport, N. Y., Gupta, R., Kim, Y.-S., & O’Neill, B. E. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.010 · Cited by 46
Sims, L. B., Huss, M. K., Frieboes, H. B., & Steinbach-Rankins, J. M. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0298-x · Cited by 43
Jiang, Z., Xiong, H., Yang, S., Lü, Y., Deng, Y., Yao, J., & Yao, J. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000075 · Cited by 43
Zhou, J., Yu, J. H., Gao, L., Sun, L., Peng, T., Wang, J., Zhu, J., Lu, W., Zhang, L., Yan, Z., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00101 · Cited by 42
Wang, Q., Li, C., Ren, T., Chen, S., Ye, X., Guo, H., He, H., Zhang, Y. X., Yin, T., Liang, X., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00612 · Cited by 41
Ets2 in Tumor Fibroblasts Promotes Angiogenesis in Breast Cancer
Wallace, J. A., Li, F., Balakrishnan, S., Cantemir-Stone, C. Z., Pécot, T., Martin, C. K., Kladney, R. D., Sharma, S. M., Trimboli, A. J., Fernández, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071533 · Cited by 40
Tumour vessel normalization takes centre stage
Cully, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.4 · Cited by 38
Modulating the rigidity of nanoparticles for tumor penetration
Deng, H., Song, K., Zhang, J., Deng, L., Dong, A., & Qin, Z. (2018) · Chemical Communications · doi:10.1039/c8cc00398j · Cited by 37
LyP-1-Modified Multifunctional Dendrimers for Targeted Antitumor and Antimetastasis Therapy
Song, N., Zhao, L., Xu, X., Zhu, M., Liu, C., Sun, N., Yang, J., Shi, X., & Zhao, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b18881 · Cited by 37
Jia, Y., & Zhu, X. X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b06909 · Cited by 34
Synthesis, formulation and in vitro evaluation of a novel microtubule destabilizer, SMART-100
Li, F., Lü, Y., Li, W., Miller, D. D., & Mahato, R. I. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.028 · Cited by 31
Yohan, D., Cruje, C., Lu, X., & Chithrani, D. B. (2014) · Nano-Micro Letters · doi:10.1007/s40820-014-0025-1 · Cited by 30
Chen, D., Monteiro-Riviere, N. A., & Zhang, L. W. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1419 · Cited by 28
Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors
Stirland, D. L., Matsumoto, Y., Toh, K., Kataoka, K., & Bae, Y. H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.016 · Cited by 25
Poloxamer-Decorated Polymer Nanoparticles for Lung Surfactant Compatibility
Beck‐Broichsitter, M., Bohr, A., & Ruge, C. A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00477 · Cited by 24
Liu, Z., Chen, W.-E., Li, Y.-H., & Xu, Q. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03927 · Cited by 23
Shi, K., Fang, Y., Gao, S., Yang, D., Bi, H., Xue, J., Lu, A., Li, Y., Ke, L., Lin, X., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.023 · Cited by 22
Self-citationZhang, X., Wang, F., Shen, Q., Xie, C., Liu, Y., Pan, J., & Lu, W. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00801 · Cited by 17
Self-citationYoshino, F., Amano, T., Zou, Y., Xu, J., Kimura, F., Furusho, Y., Chano, T., Murakami, T., Zhao, L., & Komatsu, N. (2020) · Small · doi:10.1002/smll.202003468 · Cited by 17
Fasolato, C., Giantulli, S., Capocefalo, A., Toumia, Y., Notariello, D., Mazzarda, F., Silvestri, I., Postorino, P., & Domenici, F. (2019) · Nanoscale · doi:10.1039/c9nr01075k · Cited by 15
Wu, Ramanathan, R. K., Zamboni, Strychor, Ramalingam, Edwards, R. P., Friedland, Stoller, Belani, C. P., Bang, Y., et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35751 · Cited by 8
Tunable Collagen Microfluidic Platform to Study Nanoparticle Transport in the Tumor Microenvironment
DeWitt, M. R., & Rylander, M. N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8661-3_12 · Cited by 8
Cited by
Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334
“Tumor cells may overexpress specific receptors, such as vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), folic acid (FA), integrin, CD44 (a cell surface glycoprotein), CD13, and prostate-specific membrane antigen [23].”
BackgroundLi, Z., Lai, X., Fu, S., Ren, L., Cai, H., Zhang, H., Gu, Z., Ma, X., & Luo, K. (2022) · Advanced Science · doi:10.1002/advs.202201734 · Cited by 680
Effects of nanoparticle size, shape, and zeta potential on drug delivery
Öztürk, K., Kaplan, M., & Çalış, S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124799 · Cited by 449
Recent Advances in the Development and Antimicrobial Applications of Metal–Phenolic Networks
Li, Y., Miao, Y., Yang, L., Zhao, Y., Wu, K., Lu, Z., Hu, Z., & Guo, J. (2022) · Advanced Science · doi:10.1002/advs.202202684 · Cited by 301
Injectable hydrogels as emerging drug-delivery platforms for tumor therapy
Cheng, Y., Zhang, H., Wei, H., & Yu, C.-Y. (2024) · Biomaterials Science · doi:10.1039/d3bm01840g · Cited by 65
Metadata
- Authors
- Zhang, M., Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Liu, Y., Liu, X., Su, K., & Shi, K.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 11
- Issue
- 8
- Pages
- 2265-2285
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3138372428
- Cited by
- 274
- References
- 251
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.